BioNTech SE Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
BioNTech SE (BNTX) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of -EUR 2.07 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2026-03-10
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month as first filed |
|---|---|---|
| 2025-12-31 | -2.07B EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | -1.92B EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | -2.36B EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 12.12B EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 417.80M EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 736.40M EUR 20-F · filed 2023-03-27 | 736.40M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 107.60M EUR 20-F/A · filed 2022-10-26 | 107.64M EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 239.85M EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | -106.75M EUR 20-F · filed 2020-03-31 |